Filing Details
- Accession Number:
- 0000950170-23-068887
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-07 19:45:05
- Reporting Period:
- 2023-12-05
- Accepted Time:
- 2023-12-07 19:45:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1805387 | Cerevel Therapeutics Holdings Inc. | CERE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1816720 | Scott Akamine | C/O Cerevel Therapeutics Holdings, Inc. 222 Jacobs Street, Suite 200 Cambridge MA 02141 | Chief Legal Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-12-05 | 7,500 | $13.17 | 8,013 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-12-05 | 7,500 | $35.00 | 513 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-12-07 | 10,000 | $13.17 | 10,513 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-12-07 | 10,000 | $41.37 | 513 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-12-05 | 7,500 | $0.00 | 7,500 | $13.17 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-12-07 | 10,000 | $0.00 | 10,000 | $13.17 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 264,262 | 2031-06-01 | No | 4 | M | Direct | |
| 254,262 | 2031-06-01 | No | 4 | M | Direct |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan dated August 4, 2023 adopted by the Reporting Person.
- Includes 513 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2023.
- 25% of the shares subject to this option vested and became exercisable on June 1, 2022, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
Billionaire Hedge Funds
